INVESTIGATIONAL NEW DRUGS

INVESTIGATIONAL NEW DRUGS Journal

publication venue for

Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer. 32:362-368. 2014
Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease. 26:553-559. 2008
Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid (R)) in patients with advanced solid tumors. 25:211-216. 2007
Phase 1 trial of Anvirzel (TM) in patients with refractory solid tumors. 24:423-427. 2006
Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma. 24:321-326. 2006
Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma. 22:277-284. 2004

International Standard Serial Number (ISSN)

0167-6997

Electronic International Standard Serial Number (EISSN)

1573-0646

journal abbreviation

INVEST NEW DRUG